Altfest L J & CO Inc Mirati Therapeutics, Inc. Transaction History

Altfest L J & CO Inc

  • $706 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022
SELL
$132.01 - $190.29 $171,084 - $246,615
-1,296 Closed
0 $0
Q3 2021

Oct 12, 2021
BUY
$132.13 - $177.45 $1,057 - $1,419
8 Added 0.62%
1,296 $229,000
Q2 2021

Jul 28, 2021
BUY
$144.0 - $179.73 $185,472 - $231,492
1,288 New
1,288 $208,000

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email